Pharma & Healthcare Mutual Funds in India specialize in investing in pharmaceutical companies, biotechnology firms, and related healthcare industries.
Long Horizon
20 Funds
₹30,016 Cr Total AUM
Sort By
| Fund name | Fund size | Expense Ratio | 3Y Returns  |
|---|---|---|---|
 SBI Healthcare Opportunities Fund Direct Growth Sector - Healthcare Very High Risk | ₹3,346 Cr | 0.89% | 23.9% |
 ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth Sector - Healthcare Very High Risk | ₹4,987 Cr | 1.06% | 23.7% |
 Tata India Pharma & Healthcare Fund Direct Growth Sector - Healthcare Very High Risk | ₹1,208 Cr | 0.7% | 22.5% |
 DSP Healthcare Fund Direct Growth Sector - Healthcare Very High Risk | ₹3,094 Cr | 0.6% | 22.3% |
 UTI Healthcare Fund Direct Growth Sector - Healthcare Very High Risk | ₹1,201 Cr | 1.27% | 20.6% |
 Mirae Asset Healthcare Fund Direct Growth Sector - Healthcare Very High Risk | ₹2,793 Cr | 0.48% | 20.4% |
 Nippon India Pharma Fund Direct Growth Sector - Healthcare Very High Risk | ₹8,768 Cr | 0.91% | 20.1% |
 Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth Sector - Healthcare Very High Risk | ₹888 Cr | 0.92% | 19.5% |
 LIC MF Healthcare Fund Direct Growth Sector - Healthcare Very High Risk | ₹75 Cr | 1.21% | 17.5% |
Identify red flags in your mutual funds and how to fix them
By Market Cap
By Diversification
By Sectors & Themes
By Solutions
Invest in mid-sized companies in their growth phase
Invest in the largest 250 companies in India
Invest in the largest 100 companies in India
Invest in small-sized companies in their growth phase
Tracks a market index
Hybrid funds are a combination of equity and debt investments. The blend of these asset classes varies based on the fund's investment goals.
Debt Mutual Funds invest in fixed-income securities such as government bonds, corporate bonds, treasury bills, and other money market instruments.
